IC
VIR icon

IEQ Capital’s Vir Biotechnology VIR Stock Holding History

IEQ Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Sell
66,567
-29,443
-31% -$280K ﹤0.01% 1270
2026
Q1 		$860K Buy
+96,010
New +$765K ﹤0.01% 1103
2025
Q3 		– Sell
-46,363
Closed -$234K – 2087
2025
Q2 		$234K Buy
46,363
+10,917
+31% +$58.5K ﹤0.01% 1534
2025
Q1 		$230K Buy
+35,446
New +$315K ﹤0.01% 1310

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

IEQ Capital's VIR Position: Q2 2026 in Review

IEQ Capital reduced its Vir Biotechnology (VIR) stake by 31% in Q2 2026, selling an estimated $280K and leaving 66,567 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

IEQ Capital first reported a position in VIR in Q1 2025 and has held it in 4 quarters since. The position peaked at $860K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • IEQ Capital held 66,567 shares of Vir Biotechnology worth $678K as of Q2 2026.
  • IEQ Capital sold 29,443 Vir Biotechnology shares in Q2 2026, an estimated $280K.
  • Vir Biotechnology made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1270 holding.
  • IEQ Capital first reported a position in Vir Biotechnology in Q1 2025 and has held it in 4 quarters since.
  • IEQ Capital's Vir Biotechnology position peaked at $860K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.